Swiss Chemicals Stock News

SWX:IDIA
SWX:IDIABiotechs

Does Idorsia’s Latin America QUVIVIQ Deal and Lucerastat Data Change The Bull Case For Idorsia (SWX:IDIA)?

Idorsia has recently announced an exclusive license and supply agreement with EMS S.A. to register and commercialize its insomnia medicine QUVIVIQ (daridorexant) across Latin America, while also presenting long-term data on lucerastat suggesting disease-modifying potential in Fabry disease at the WORLDSymposium. Together, these developments highlight Idorsia’s push to expand QUVIVIQ into new geographies and progress lucerastat toward a defined regulatory path in a rare disease setting. We’ll...
SWX:PGHN
SWX:PGHNCapital Markets

Is Partners Group (SWX:PGHN) Quietly Reframing Its Competitive Edge Through Streamlined Private Markets Access?

In January 2026, BlackRock and Partners Group launched a first-of-its-kind multi-alternatives separately managed account on the Morgan Stanley wealth platform, giving advisors streamlined access to diversified private equity, private credit, and real assets through three outcome-aligned strategies. This structure is designed to remove common barriers to private market access by consolidating seven evergreen private market funds into a single, operationally simple solution for financial...
SWX:COPN
SWX:COPNPharmaceuticals

Cosmo Pharmaceuticals (SWX:COPN): Does the New Institutional Stake Redefine Its Capital Allocation Playbook?

Cosmo Pharmaceuticals N.V. recently completed a private placement of 937,086 treasury shares, equivalent to about 5.3% of its outstanding shares, with Capital Group’s SMALLCAP World Fund, using only existing treasury stock and therefore avoiding dilution for current shareholders. The deal brings a globally recognized institutional investor into Cosmo’s shareholder base while providing additional financial flexibility to support its MedTech AI, dermatology, gastroenterology, and CDMO...
SWX:SIKA
SWX:SIKAChemicals

How Sika’s Global Plant Expansion Will Impact Sika (SWX:SIKA) Investors

Sika recently expanded its global manufacturing network by opening five new plants in the United States, Argentina, Colombia, Bangladesh, and Tanzania to increase production capacity and reinforce its supply chain in key regions. This expansion underscores Sika’s emphasis on being closer to customers in growth markets, enhancing supply reliability and responsiveness across diverse construction material needs. We’ll now examine how this push to boost production capacity in key growth markets...
SWX:ADEN
SWX:ADENProfessional Services

Assessing Adecco Group’s (SWX:ADEN) Valuation After The New LHH Global HR Consulting Platform Launch

Adecco Group (SWX:ADEN) is back in focus after launching a global HR and talent consulting platform under its LHH brand. The move puts more weight on advisory services ahead of the upcoming earnings release. See our latest analysis for Adecco Group. The LHH launch comes as Adecco’s CHF23.20 share price sits slightly lower year to date, with a 4.3% 90 day share price return and an 11.5% 1 year total shareholder return, suggesting recent momentum has picked up after a weaker multi year...
SWX:AMS
SWX:AMSSemiconductor

Does ams-OSRAM’s Shift Toward Higher-Margin Optical Chips Transform The Bull Case For ams-OSRAM (SWX:AMS)?

ams-OSRAM’s ongoing turnaround has involved restructuring and moving away from low-margin LED activities toward automotive and industrial optical semiconductor applications, with management stressing operational improvements and debt reduction as priorities. An interesting angle is how investors and analysts are closely watching AI-driven demand for optical sensors as a potential earnings catalyst, while still highlighting considerable execution and leverage risks. Next, we’ll examine how...
SWX:UBSG
SWX:UBSGCapital Markets

UBS Elevates Hinnen To Lead APAC Premium Advisory Wealth Push

UBS Group (SWX:UBSG) has appointed Nicholas Hinnen as head of premium advisory specialists APAC Switzerland. The newly created role oversees a cross asset advisory team for ultra high and high net worth wealth management clients. The promotion reflects UBS's focus on its Swiss based affluent client segment and tailored advisory services. For you as an investor, this move highlights how UBS is leaning into its core wealth management franchise, where personalised advice and cross asset...
SWX:YPSN
SWX:YPSNMedical Equipment

Assessing Ypsomed Holding’s (SWX:YPSN) Valuation After Expanded BD Collaboration On Large Volume Autoinjectors

BD and Ypsomed Holding (SWX:YPSN) are expanding their collaboration around a new 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe, tailored for Ypsomed’s YpsoMate 5.5 large volume autoinjector platform. See our latest analysis for Ypsomed Holding. Despite the expanded BD partnership around large volume injectors, Ypsomed Holding’s 1 day share price return of 0.16% comes after a softer patch, with a 30 day share price return of 6.71% and a 1 year total shareholder return of 12.36%. This...
SWX:HIAG
SWX:HIAGReal Estate

Assessing HIAG Immobilien Holding (SWX:HIAG) Valuation After Strong 2025 Profit Guidance And Recent Share Price Momentum

HIAG Immobilien Holding (SWX:HIAG) has drawn attention after issuing new guidance indicating that its 2025 consolidated net profit is expected to be 50% to 55% higher than the 2024 figure of CHF 75.2 million. See our latest analysis for HIAG Immobilien Holding. The updated profit outlook arrives after a solid run in HIAG Immobilien Holding's share price, with a 30 day share price return of 4.89%, a 90 day share price return of 13.09% and a 1 year total shareholder return of 45.44%, which...
SWX:ADEN
SWX:ADENProfessional Services

Does LHH’s New HR Consulting Push Change The Bull Case For Adecco Group (SWX:ADEN)?

Adecco Group’s LHH brand recently launched a global HR and talent consulting business, aiming to expand its higher-value advisory and support offerings. This move signals a push toward more consultative, margin-rich services that could reshape how Adecco balances traditional staffing with broader workforce solutions. Next, we’ll examine how this LHH consulting launch influences Adecco’s investment narrative, particularly its push into higher-margin HR services. Trump's oil boom is here -...
SWX:LAND
SWX:LANDElectronic

A Look At Landis+Gyr Group’s Valuation As Mitsubishi Electric Partnership Advances Grid Edge Plans

Mitsubishi Electric Corporation and Landis+Gyr Group (SWX:LAND) have signed a Memorandum of Understanding to work together on grid edge intelligence and energy transition solutions, initially targeting North American utilities. See our latest analysis for Landis+Gyr Group. The Mitsubishi Electric agreement lands after a recent Q3 sales or trading statement call and comes as the share price sits at CHF54.3, with a 7 day share price return of 6.68% but a 1 year total shareholder return of 8.23%...
SWX:BEAN
SWX:BEANBuilding

Did BELIMO’s 23.3% Sales Surge in 2025 Just Shift BELIMO Holding's (SWX:BEAN) Investment Narrative?

In January 2026, BELIMO Holding AG reported its 2025 results, revealing accelerated sales growth of 23.3% in local currencies and CHF 1,121 million in sales. This sharp step-up in growth relative to the prior year highlights how BELIMO’s offering is gaining traction across its key end markets. We’ll now examine how this acceleration in sales growth shapes BELIMO’s investment narrative and what it could mean for investors. The end of cancer? These 29 emerging AI stocks are developing tech...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Is Up 10.4% After New Buyback And Record Q4 2025 - Has The Bull Case Changed?

ABB Ltd has completed its 2025 share buyback, reported record fourth-quarter 2025 results with higher revenue and earnings, and announced a new US$2.00 billion share repurchase program running through January 27, 2027 for capital reduction and employee share plans. The company coupled the buyback with guidance for comparable revenue growth of 7%–10% for the first quarter and 6%–9% for full-year 2026, highlighting confidence backed by a record order backlog and expanding electrification and...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG) Net Margin Jump To 20.3% Tests Long Term EPS Bear Case

How Roche Holding (SWX:ROG) Just Framed Its FY 2025 Story Roche Holding (SWX:ROG) opened FY 2025 with first half revenue of CHF31.8b and basic EPS of CHF9.31, setting the tone with headline numbers that put both the top line and per share earnings clearly on the radar for investors following this latest update. Over the recent reporting periods, revenue has moved from CHF30.8b in the first half of 2024 to CHF31.6b in the second half and then to CHF31.8b in the first half of 2025. Basic EPS...
SWX:BARN
SWX:BARNFood

Cocoa Volume Slump And Value Focus Might Change The Case For Investing In Barry Callebaut (SWX:BARN)

In late January 2026, Barry Callebaut reported a 22% decline in cocoa division sales volume for the quarter ended November 30, citing weak global demand and a tilt toward higher-return product segments against a backdrop of abundant cocoa supplies and pressured prices. This combination of softer end-consumer appetite for chocolate and a deliberate focus on more profitable cocoa uses signals an important shift in how Barry Callebaut is balancing volume and value across its business. We will...
SWX:UBXN
SWX:UBXNSemiconductor

A Look At u‑blox Holding (SWX:UBXN) Valuation As AI Demand And Earnings Outlook Draw Attention

AI driven demand puts u-blox Holding (SWX:UBXN) in focus ahead of earnings Market attention has turned to u-blox Holding (SWX:UBXN) as investors weigh its role in AI related GNSS and wireless modules, and look ahead to earnings, with revenue mix and margin recovery under scrutiny. See our latest analysis for u-blox Holding. After a strong run, with an 81.21% year to date share price return and a 108.01% total shareholder return over the past year, recent gains around AI related GNSS demand...
SWX:AMRZ
SWX:AMRZBasic Materials

Is Amrize’s (SWX:AMRZ) Q4 Earnings Call Set To Reframe Its Long-Term Growth Narrative?

Amrize has announced it will release its fourth-quarter 2025 results after the U.S. market closes on February 17, 2026, followed by a webcast the next morning to discuss the numbers with investors. Fresh analyst coverage, including updated ratings and commentary, is sharpening market attention on how these upcoming results could shape perceptions of Amrize’s outlook. We’ll now examine how the upcoming fourth-quarter earnings release and related analyst commentary may influence Amrize’s...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Net Margin Improvement Tests Justification For Premium P/E Valuation

How ABB (SWX:ABBN)'s FY 2025 Numbers Set the Stage ABB (SWX:ABBN) closed FY 2025 with fourth quarter revenue of US$9.1b and basic EPS of US$0.70, alongside trailing twelve month revenue of US$33.2b and EPS of US$2.50 that frame the full year picture. Over recent periods, the company has seen quarterly revenue range from US$7.9b to just over US$9.0b and EPS move from US$0.54 in Q4 2024 through to US$0.70 in Q4 2025, giving investors a clear read on how the top line and per share earnings have...